Insulet Corporation

This is one of the most impactful committees for Insulet, controlling taxation (corporate tax rates, credits) and entitlement spending (Medicare and Medicaid). These programs are major reimbursement sources for medical devices, directly affecting Insulet's revenue and profitability.

This committee directly allocates discretionary federal spending. Its subcommittees fund agencies critical to Insulet's business, such as HHS (which houses FDA and CMS), directly impacting regulatory capacity, research grants, and reimbursement for medical devices.

This committee directly regulates the FDA, which is responsible for approving medical devices like those Insulet manufactures. It also influences NIH funding for research and development, and labor laws impacting manufacturing costs.

This committee oversees intellectual property (patents), which is crucial for protecting medical device innovations. It also handles antitrust laws, influencing M&A activity within the consolidating healthcare industry.

The Department of Veterans Affairs is a major healthcare provider and procurer of medical devices. This committee's funding decisions directly impact a significant potential customer and reimbursement source for Insulet's products.